BEUDAMED
    12 results · 20ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Regulation: Us FDA ×

    CHASE SUCKER

    FDA 510(k)
    FDA Class 2 ·General Hospital

    NA

    FDA UDI
    KEY SURGICAL, INC.·10849771048746·K-Wires, Double trocar, .035-inch (0.9mm) diame...

    KMEDIC

    FDA UDI
    TELEFLEX INCORPORATED·24026704292374·

    mahe medical GmbH

    FDA UDI
    mahe medical gmbh·04050659483927·K-Wire w. double end trocarpoint _x000D_...

    K-Wire w. double end trocarpoint 0.90mm/152mm, 6 pcs./unit

    FDA UDI
    mahe medical gmbh·EMAHKM710220·K-Wire w. double end trocarpoint 0.90mm...

    POWDER-FREE VINYL EXAMINATION GLOVES

    FDA 510(k)
    FDA Class 1 ·General Hospital

    Ablation Confirmation

    FDA 510(k)
    FDA Class 2 ·Radiology

    1.5MM CORTEX SCREW SLF-TPING WITH T4 STARDRIVE RECESS 12MM

    FDA Adverse Event
    Injury ·SYNTHES USA·Product code HRS·February 21, 2013

    MANUAL ORTHOPEDIC SURGICAL INSTRUMENT

    FDA Adverse Event
    Malfunction ·MEDTRONIC SOFAMOR DANEK INSTRUMENT MANUFACTURING·Product code HXW·January 26, 2011

    GRANUFLO

    FDA Adverse Event
    Injury ·FRESENIUS MEDICAL CARE NORTH AMERICA·Product code KPO·July 8, 2014

    FEMALE LL ADAPTOR

    FDA Adverse Event
    Malfunction ·BECTON DICKINSON·Product code FPA·January 7, 2021

    Anthem Model Numbers: PM3210, PM3212; Allure/Relieve Model Numbers: PM3222, PM3242, PM3262, PM3542, PM3224, PM3244 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration

    FDA Enforcement
    Class II ·Terminated·St Jude Medical Inc.·October 25, 2017